» Articles » PMID: 7356690

Time-course of Insulin Degradation in Perifused Isolated Rat Adipose Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1980 Feb 1
PMID 7356690
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Isolated fat cells from rat epididymal adipose tissue were preincubated with 50 microU/ml (0.33 nM) 125I-insulin at 23 degrees C to enhance binding while retarding degradation. The fat cells were then perifused at that temperature to remove unbound 125I-insulin, and fractions of perifusate were collected each minute. The temperature of the cells in the perifusion chamber was then rapidly increased to 37 degrees C, and perifusion was continued. The fat cells degraded a portion of the bound 125I-insulin measured by loss of immunoprecipitability with excess antisera to insulin. The percentage of degraded 125I-insulin dissociating from the fat cells increased progressively with time at 37 degrees C, and the rateof dissociation of 125I-insulin degradation products showed a first-order dependence on the amount of degraded 125I-insulin bound to the cells. To explain this first-order dependence it is necessary to postulate a "processing" step after binding and before degradation. The first-order rate constant at 37 degrees C is 0.023 +/- 0.004 min-1. Fast and slow dissociating components can be resolved from kinetic plots of the dissociation of undegraded 125I-insulin (immunoprecipitable) from the isolated fat cells. The antilipolytic activity of the 125I-insulin on epinephrine-stimulated lipolysis is evident over much of the time-course of dissociation. A model for the degradation of insulin bound to isolated fat cells is discussed.

Citing Articles

A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System.

Schaller S, Willmann S, Lippert J, Schaupp L, Pieber T, Schuppert A CPT Pharmacometrics Syst Pharmacol. 2013; 2:e65.

PMID: 23945606 PMC: 3828004. DOI: 10.1038/psp.2013.40.


Affinity change of the adipocyte receptor fails to alter insulin-stimulated glucose transport.

McCaleb M, Donner D Biochem J. 1982; 202(1):263-5.

PMID: 7044377 PMC: 1158101. DOI: 10.1042/bj2020263.


Receptor- and non-receptor-mediated uptake and degradation of insulin by hepatocytes.

Donner D Biochem J. 1982; 208(1):211-9.

PMID: 6760855 PMC: 1153948. DOI: 10.1042/bj2080211.


Insulin degradation in human erythrocytes. Effect of triton X-100 treatment on insulin-degrading activity of membranes.

Bellomo G, Nicotera P, Parini A, Fratino P J Endocrinol Invest. 1983; 6(6):441-4.

PMID: 6368662 DOI: 10.1007/BF03348343.


Glucagon degradation by human mononuclear cells.

Neal G, Solomon S, Shankar T, Duckworth W Diabetologia. 1983; 25(5):404-10.

PMID: 6317504 DOI: 10.1007/BF00282519.


References
1.
Carpentier J, Gorden P, Amherdt M, Van Obberghen E, Kahn C, Orci L . 125I-insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography. J Clin Invest. 1978; 61(4):1057-70. PMC: 372623. DOI: 10.1172/JCI109005. View

2.
Knight M, Klee W . The relationship between enkephalin degradation and opiate receptor occupancy. J Biol Chem. 1978; 253(11):3843-7. View

3.
Kahn C, Baird K . The fate of insulin bound to adipocytes. Evidence for compartmentalization and processing. J Biol Chem. 1978; 253(14):4900-6. View

4.
Olefsky J, Chang H . Insulin binding to adipocytes. Evidence for functionally distinct receptors. Diabetes. 1978; 27(9):946-58. DOI: 10.2337/diab.27.9.946. View

5.
Duckworth W . Insulin and glucagon binding and degradation by kidney cell membranes. Endocrinology. 1978; 102(6):1766-74. DOI: 10.1210/endo-102-6-1766. View